Cytokines and soluble tumour necrosis factor I receptor levels during pretransplant conditioning in allogeneic stem-cell transplantation

被引:6
作者
Andersen, J
Heilmann, C
Jacobsen, N
Bendtzen, K
Müller, K
机构
[1] Natl Univ Hosp, Pediat Clin 2 4064, Rigshosp, DK-2100 Copenhagen, Denmark
[2] Natl Univ Hosp, Inst Inflammat Res, Rigshosp, DK-2100 Copenhagen, Denmark
[3] Natl Univ Hosp, Haematol Clin 2, Rigshosp, DK-2100 Copenhagen, Denmark
关键词
stem-cell transplantation; chemotherapy; total body irradiation; cyclophosphamide; tumour necrosis factor alpha; interleukins; soluble tumour necrosis factor receptor I;
D O I
10.1016/j.intimp.2004.09.021
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The inflammatory response induced by the conditioning regime may be related to the outcome in allogeneic stem-cell transplantation (SCT). However, previous statements concerning the prognostic significance of cytokine measurements during conditioning have not been conclusive. We investigated a broad range of cytokines in plasma samples drawn daily immediately before start of pretransplant conditioning and during the conditioning. The presented data indicate that single-day measurements of inflammatory cytokines during conditioning may lead to unreliable conclusions concerning their prognostic significance. However. serial quantitation of soluble tumour necrosis factor receptor I (sTNFRI) is more likely to reflect the degree of inflammatory activation induced by pretransplant conditioning. (C) 2004 Published by Elsevier B.V.
引用
收藏
页码:67 / 71
页数:5
相关论文
共 17 条
[1]
Plasma cytokines in graft vs host disease and complications following bone marrow transplantation [J].
Abdallah, AN ;
Boiron, JM ;
Attia, Y ;
Cassaigne, A ;
Reiffers, J ;
Iron, A .
HEMATOLOGY AND CELL THERAPY, 1997, 39 (01) :27-32
[2]
INTERLEUKIN-1 IS A CRITICAL EFFECTOR MOLECULE DURING CYTOKINE DYSREGULATION IN GRAFT-VERSUS-HOST DISEASE TO MINOR HISTOCOMPATIBILITY ANTIGENS [J].
ABHYANKAR, S ;
GILLILAND, DG ;
FERRARA, JLM .
TRANSPLANTATION, 1993, 56 (06) :1518-1523
[3]
Production of interleukin (IL)-1β, IL-1 receptor antagonist and IL-10 by blood mononuclear cells in chronic arthritis [J].
Andersen, LS ;
Petersen, J ;
Bendtzen, K .
CYTOKINE, 2000, 12 (01) :62-68
[4]
RECOMBINANT HUMAN INTERLEUKIN-1 RECEPTOR ANTAGONIST IN THE TREATMENT OF STEROID-RESISTANT GRAFT-VERSUS-HOST DISEASE [J].
ANTIN, JH ;
WEINSTEIN, HJ ;
GUINAN, EC ;
MCCARTHY, P ;
BIERER, BE ;
GILLILAND, DG ;
PARSONS, SK ;
BALLEN, KK ;
RIMM, IJ ;
FALZARANO, G ;
BLOEDOW, DC ;
ABATE, L ;
LEBSACK, M ;
BURAKOFF, SJ ;
FERRARA, JLM .
BLOOD, 1994, 84 (04) :1342-1348
[5]
High spontaneous IL-10 production in unrelated bone marrow transplant recipients is associated with fewer transplant-related complications and early deaths [J].
Baker, KS ;
Roncarolo, MG ;
Peters, C ;
Bigler, M ;
DeFor, T ;
Blazar, BR .
BONE MARROW TRANSPLANTATION, 1999, 23 (11) :1123-1129
[6]
CYTOKINES AND NATURAL REGULATORS OF CYTOKINES [J].
BENDTZEN, K .
IMMUNOLOGY LETTERS, 1994, 43 (1-2) :111-123
[7]
CHASTY RC, 1993, BONE MARROW TRANSPL, V12, P331
[8]
BLOCKING IL-1 - INTERLEUKIN-1 RECEPTOR ANTAGONIST INVIVO AND INVITRO [J].
DINARELLO, CA ;
THOMPSON, RC .
IMMUNOLOGY TODAY, 1991, 12 (11) :404-410
[9]
FERRARA JLM, 1999, BONE MARROW TRANSPL, P305
[10]
HERVE P, 1992, BLOOD, V79, P3362